Varicella-Zoster Virus (VZV) glycoprotein E is a serological antigen for detection of intrathecal antibodies to VZV in central nervous system infections, without cross-reaction to herpes simplex virus 1

Clinical and Vaccine Immunology

Volumn 18, Issue 8, 2011, Pages 1336-1342

  Grahn, Anna ^a   Studahl, Marie ^a   Nilsson, Staffan ^b   Thomsson, Elisabeth ^c   Bäckström, Malin ^c   Bergström, Tomas ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN E; IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD ANALYSIS; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL ARTICLE; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 1; HUMAN; MALE; OPTICAL DENSITY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SERODIAGNOSIS; VARICELLA ZOSTER VIRUS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CHILD, PRESCHOOL; CLINICAL LABORATORY TECHNIQUES; ENCEPHALITIS, VARICELLA ZOSTER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPESVIRUS 1, HUMAN; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; VIRAL ENVELOPE PROTEINS;

EID: 79961105057     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05061-11     Document Type: Article

References (28)

1. Aurelius, E., B. Johansson, B. Skoldenberg, A. Staland, and M. Forsgren. 1991. Rapid diagnosis of herpes simplex encephalitis by nested polymerase chain reaction assay of cerebrospinal fluid. Lancet 337:189-192.
2. Breuer, J., D. S. Schmid, and A. A. Gershon. 2008. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella. J. Infect. Dis. 197(Suppl. 2):S147-S151. (Pubitemid 351590163)
3. Casas, I., A. Tenorio, F. de Ory, A. Lozano, and J. M. Echevarria. 1996. Detection of both herpes simplex and varicella-zoster viruses in cerebrospinal fluid from patients with encephalitis. J. Med. Virol. 50:82-92. (Pubitemid 26348947)
4. Edson, C. M., B. A. Hosler, R. A. Respess, D. J. Waters, and D. A. Thorley-Lawson. 1985. Cross-reactivity between herpes simplex virus glycoprotein B and a 63,000-dalton varicella-zoster virus envelope glycoprotein. J. Virol. 56:333-336. (Pubitemid 16214123)
5. Forghani, B., N. J. Schmidt, and J. Dennis. 1978. Antibody assays for varicella- zoster virus: comparison of enzyme immunoassay with neutralization, immune adherence hemagglutination, and complement fixation. J. Clin. Microbiol. 8:545-552. (Pubitemid 9052791)
6. Gilden, D., R. J. Cohrs, R. Mahalingam, and M. A. Nagel. 2009. Varicella zoster virus vasculopathies: diverse clinical manifestations, laboratory features, pathogenesis, and treatment. Lancet Neurol. 8:731-740.
7. Gregoire, S. M., V. van Pesch, S. Goffette, A. Peeters, and C. J. Sindic. 2006. PCR analysis and oligoclonal antibody in the cerebrospinal fluid from 34 patients with varicella-zoster virus infection of the nervous system. J. Neurol. Neurosurg. Psychiatry 77:938-942. (Pubitemid 44174078)
8. Hansen, K., M. Cruz, and H. Link. 1990. Oligoclonal Borrelia burgdorferi-specific IgG antibodies in cerebrospinal fluid in Lyme neuroborreliosis. J. Infect. Dis. 161:1194-1202. (Pubitemid 20177880)
9. Haumont, M., et al. 1996. Purification, characterization and immunogenicity of recombinant varicella-zoster virus glycoprotein gE secreted by Chinese hamster ovary cells. Virus Res. 40:199-204.
10. Hedman, L., M. Soderlund-Venermo, T. Jartti, O. Ruuskanen, and K. Hedman. 2010. Dating of human bocavirus infection with protein-denaturing IgG-avidity assays - secondary immune activations are ubiquitous in immunocompetent adults. J. Clin. Virol. 48:44-48.
11. Jeansson, S., M. Forsgren, and B. Svennerholm. 1983. Evaluation of solubilized herpes simplex virus membrane antigen by enzyme-linked immunosorbent assay. J. Clin. Microbiol. 18:1160-1166. (Pubitemid 13015949)
12. Keller, P. M., K. Lonergan, B. J. Neff, D. A. Morton, and R. W. Ellis. 1986. Purification of individual varicella-zoster virus (VZV) glycoproteins gpI, gpII, and gpIII and their use in ELISA for detection of VZV glycoprotein-specific antibodies. J. Virol. Methods 14:177-188. (Pubitemid 17175901)
13. Kitamura, K., J. Namazue, H. Campo-Vera, T. Ogino, and K. Yamanishi. 1986. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB. Virology 149:74-82. (Pubitemid 16174980)
14. Koskiniemi, M., et al. 2002. Acute central nervous system complications in varicella zoster virus infections. J. Clin. Virol. 25:293-301. (Pubitemid 35287567)
15. Kuhn, J. E., K. Klaffke, K. Munk, and R. W. Braun. 1990. HSV-1 gB and VZV gp-II crossreactive antibodies in human sera. Arch. Virol. 112:203-213. (Pubitemid 20277122)
16. Kutinova, L., P. Hainz, V. Ludvikova, L. Maresova, and S. Nemeckova. 2001. Immune response to vaccinia virus recombinants expressing glycoproteins gE, gB, gH, and gL of varicella-zoster virus. Virology 280:211-220. (Pubitemid 34165351)
17. Linde, A., et al. 1997. Specific diagnostic methods for herpesvirus infections of the central nervous system: a consensus review by the European Union Concerted Action on Virus Meningitis and Encephalitis. Clin. Diagn. Virol. 8:83-104. (Pubitemid 27397833)
18. Montalvo, E. A., R. T. Parmley, and C. Grose. 1985. Structural analysis of the varicella-zoster virus gp98-gp62 complex: posttranslational addition of N-linked and O-linked oligosaccharide moieties. J. Virol. 53:761-770. (Pubitemid 15173278)
19. Persson, A., T. Bergstrom, M. Lindh, L. Namvar, and M. Studahl. 2009. Varicella-zoster virus CNS disease - viral load, clinical manifestations and sequels. J. Clin. Virol. 46:249-253.
20. Puchhammer-Stockl, E., T. Popow-Kraupp, F. X. Heinz, C. W. Mandl, and C. Kunz. 1991. Detection of varicella-zoster virus DNA by PCR in the cerebrospinal fluid of patients suffering from neurological complications associated with chicken pox or herpes zoster. J. Clin. Microbiol. 29:1513-1516.
21. Raschilas, F., et al. 2002. Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study. Clin. Infect. Dis. 35:254-260. (Pubitemid 34800272)
22. Roberg, M., P. Forsberg, A. Tegnell, and K. Ekerfeldt. 1995. Intrathecal production of specific IgA antibodies in CNS infections. J. Neurol. 242:390-397.
23. Schmidt, N. J., E. H. Lennette, and R. L. Magoffin. 1969. Immunological relationship between herpes simplex and varicella-zoster viruses demonstrated by complement-fixation, neutralization and fluorescent antibody tests. J. Gen. Virol. 4:321-328.
24. Schultze, D., et al. 2004. Diagnostic significance of intrathecally produced herpes simplex and varizella-zoster virus-specific antibodies in central nervous system infections. Swiss Med. Wkly. 134:700-704. (Pubitemid 40023595)
25. Skoldenberg, B. 1991. Herpes simplex encephalitis. Scand. J. Infect. Dis. Suppl. 80:40-46.
26. Studahl, M., T. Bergstrom, and L. Hagberg. 1998. Acute viral encephalitis in adults - a prospective study. Scand. J. Infect. Dis. 30:215-220. (Pubitemid 28461587)
27. Thomsson, E., et al. 2011. Recombinant glycoprotein E produced in mammalian cells in large-scale as an antigen for varicella-zoster-virus serology. J. Virol. Methods 175:53-59.
28. Vandvik, B., et al. 1985. Long-term persistence of intrathecal virus-specific antibody responses after herpes simplex virus encephalitis. J. Neurol. 231:307-312. (Pubitemid 15197058)